Cytochalasin E
-
Cytochalasin E
structure -
-
CAS No:
36011-19-5
-
Formula:
C28H33NO7
-
Chemical Name:
Cytochalasin E
-
Synonyms:
[1,3]Dioxacyclotridecino[4,5-d]oxireno[f]isoindole-5,10,12(4H,6H)-trione,3,13,14,14a,15,15a,16a,16b-octahydro-6-hydroxy-4,6,15,15a-tetramethyl-14-(phenylmethyl)-,(1E,4S,6R,7E,11aS,14S,14aS,15S,15aR,16aS,16bS)-;21,23-Dioxa[13]cytochalasa-13,19-diene-1,17,22-trione,6,7-epoxy-18-hydroxy-16,18-dimethyl-10-phenyl-,(7S,13E,16S,18R,19E)-;(1E,4S,6R,7E,11aS,14S,14aS,15S,15aR,16aS,16bS)-3,13,14,14a,15,15a,16a,16b-Octahydro-6-hydroxy-4,6,15,15a-tetramethyl-14-(phenylmethyl)[1,3]dioxacyclotridecino[4,5-d]oxireno[f]isoindole-5,10,12(4H,6H)-trione;Cytochalasin E;[1,3]Dioxacyclotridecino[4,5-d]oxireno[f]isoindole-5,10,12(4H,6H)-trione,3,13,14,14a,15,15a,16a,16b-octahydro-6-hydroxy-4,6,15,15a-tetramethyl-14-(phenylmethyl)-,[4S-(1E,4R*,6S*,7E,11aR*,14R*,14aR*,15R*,15aS*,16aR*,16bR*)]-;NSC 175151;12623-99-3
-
CAS No:
Description
Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. Cytochalasin E is a potent actin depolymerization agent, and it binds and caps the barbed end of actin filaments to prevent actin elongation[1][2].
Characteristics
114.46000
1.92
1.3±0.1 g/cm3
206-208 °C (decomp)
587.59°C (rough estimate)
380.2±32.9 °C
1.608
SOL IN DICHLOROMETHANE, CHLOROFORM, ACETONE, & METHANOL; SPARINGLY SOL IN WATER
−20°C
SPECIFIC OPTICAL ROTATION: -25.6 DEG @ 25 °C/D (IN METHANOL); WEAK ABSORPTIONS BETWEEN 240 & 300 NM DUE IN PART TO THE PI BOND TO PI BOND* TRANSITION OF THE MONOSUBSTITUTED AROMATIC RING
THE CYTOCHALASINS GENERALLY CAN BE DESCRIBED AS A PHENYLALANINE OR TRYPTOPHAN MOIETY LINKED TO PERHYDROISOINDOLE MOIETY WHICH IS IN TURN LINKED TO A C16-C18 POLYKETIDE RING SYSTEM CONTAINING A CARBOCYCLIC (CYTOCHALASIN C), A LACTONE (CYTOCHALASIN A), OR A CYCLIC CARBONATE (CYTOCHALASIN E) MOIETY /CYTOCHALASINS/
Safety Information
I
6.1(a)
UN 1544 6.1/PG 2
3
26/27/28-63
28-36/37-45
HA5360000
T+,T
UNSTABLE IN CHLOROFORM SOLN & UNDER ACIDIC CONDITIONS.
P260-P264-P280-P284-P301 + P310-P302 + P350
H300-H310-H330-H361
|Danger|H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]|P201, P202, P260, P262, P264, P270, P271, P280, P281, P284, P301+P310, P302+P350, P304+P340, P308+P313, P310, P320, P321, P322, P330, P361, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Toxicity
A CLASS OF MOLD METABOLITES EXHIBITING INHIBITORY EFFECTS ON CELL PROCESSES. SIX CYTOCHALASINS HAVE BEEN ISOLATED: CYTOCHALASINS A, B & F FROM HELMINTHOSPORIUM DEMATIOIDEUM; C & D FROM METARRHIZIUM ANISOPLIAE; E FROM ROSELLINIA NECATRIX. /CYTOCHALASINS/|FUNGAL SOURCE: ROSELLINIA NECUTRIX & ASPERGILLUS CLAVATUS.
Drug Information
Angiogenesis Inhibitors
Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)
MAJOR BIOLOGICAL EFFECTS ARE THE BLOCKAGE OF CYTOPLASMIC CLEAVAGE RESULTING IN MULTINUCLEATE CELL FORMATION, THE INHIBITION OF CELL MOVEMENT, & THE INDUCTION OF NUCLEAR EXTRUSION... OTHER REPORTED EFFECTS INCLUDE THE INHIBITION OF GLUCOSE TRANSPORT, OF THYROID SECRETION, OF GROWTH HORMONE RELEASE, OF PHAGOCYTOSIS, & OF PLATELET AGGREGATION & CLOT CONTRACTION. /CYTOCHALASINS/|THE INFLUENCE OF CYTOCHALASIN B & E ON INTESTINAL DIGESTION OF MALTOSE & SUCROSE, & THEIR DIGESTION PRODUCTS AS GLUCOSE & FRUCTOSE WAS INVESTIGATED IN THE MOUSE IN VITRO. NEITHER DIGESTION OF MALTOSE OR SUCROSE NOR ACTIVITIES OF MALTASE OR SUCRASE IN EVERTED SACS OF MOUSE JEJUNUM WAS AFFECTED BY CYTOCHALASIN B OR E AT 5.0 & 10.0 MUG/ML AFTER 60 MIN INCUBATION. HOWEVER, ABSORPTION OF GLUCOSE DERIVED FROM MALTOSE OR SUCROSE DIGESTION WAS INHIBITED BY 68.5 & 65.9% DUE TO CYTOCHALASIN E (5.0 MUG/ML) & BY 29.5 & 13.1% DUE TO CYTOCHALASIN B AT THE SAME CONCN. CYTOCHALASINS B & E SEEMED TO STIMULATE ABSORPTION OF FRUCTOSE DERIVED FROM SUCROSE DIGESTION IN MOUSE JEJUNUM.|THE INHIBITORY EFFECT OF CYTOCHALASIN E ON GALACTOSE ABSORPTION IN EVERTED SACS OF MOUSE JEJUNUM WAS STUDIED. CYTOCHALASIN B HAD THE HIGHEST POTENCY ON THE INHIBITION OF GALACTOSE ABSORPTION WHEN IT WAS ADDED IN THE MUCOSAL SOLN FOLLOWED BY CYTOCHALASIN E, A, C, & D, RESPECTIVELY.|IN MICE Y-1 ADRENAL TUMOR CELLS, CYTOCHALASINS E, D, B, & H2B, INHIBITED STEROIDOGENESIS & PRODUCED ROUNDING OF CELLS BY INTERFERING WITH POLYMERIZATION OF ACTIN & NOT AS THE RESULT OF EFFECTS UNRELATED TO BINDING TO ACTIN.|For more Mechanism of Action (Complete) data for CYTOCHALASIN E (10 total), please visit the HSDB record page.
IN PURIFIED HUMAN PERIPHERAL BLOOD LYMPHOCYTES, LOW (0.01-10 MUMOL) CONCN OF CYTOCHALASINS A, B, E, & D PRODUCED MARKED AUGMENTATION OF TRANSPORT & METABOLIC RESPONSES TO PHYTOHEMAGGLUTININ (PHA) & CONCANAVALIN A (CON A), INCLUDING EFFECTS ON DNA SYNTHESIS, CYCLIC AMP ACCUMULATION, PHOSPHATIDYLINOSITOL TURNOVER, & SODIUM-DEPENDENT AMINO ACID TRANSPORT.|TREATMENT OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES (PMNS) WITH CYTOCHALASIN E (CE), CYTOCHALASIN D (CD), CYTOCHALASIN B (CB), AND DIHYDROCYTOCHALASIN D (H2CB) RESULTS IN ALTERATION OF CELL MORPHOLOGY & INHIBITION OF CELL MOTILITY. MORPHOLOGICAL CHANGES ARE SIMILAR TO THOSE REPORTED FOR NONAMEBOID FIBROBLASTS: ROUNDING, ZEIOSIS, & ARBORIZATION. MEAN CELL VELOCITY OF PMNS, AS MEASURED BY QUANTITATIVE ANALYSIS OF TIME-LAPSE VIDEOTAPE RECORDINGS, WAS REDUCED TO 0.1 MUM/MIN (CONTROL, 7.3 MUM/MIN). PHAGOCYTOSIS BY PMNS, AS MEASURED BY PHAGOCYTOSIS OF LATEX BEADS, WAS INHIBITED BY 75%.|THERE HAS BEEN NO REPORT ON CHRONIC TOXICITY & CARCINOGENICITY OF CYTOCHALASINS... ALTHOUGH MANY CYTOLOGICAL STUDIES HAVE BEEN DONE, THE VARIETY OF EFFECTS THUS FAR OBSERVED INDICATE THE IMPORTANCE OF THE COMPOUNDS FOR ANIMAL & HUMAN HEALTH. ...STRONG ACUTE TOXICITIES EXHIBITED BY SOME CYTOCHALASINS & THE WIDE NATURAL OCCURRENCE OF THE FUNGI THAT PRODUCE CYTOCHALASINS SHOULD BE CONSIDERED IN FUTURE STUDIES ON MYCOTOXINS. /CYTOCHALASINS/
cytochalasin E
Cytochalasin E Use and Manufacturing
ISOLATION & STRUCTURE OF CYTOCHALASINS E & F: ALDRIDGE ET AL, CHEM COMMUN 1972, 148. /CYTOCHALASINS/
Cytochalasin E is one of a family of potent mycotoxins produced by a range of fungi. All members of the class exhibit profound effects on cytoskeletal proteins, resulting in pronounced morphogenic changes in animals and plants. Despite the common mode of action, there is evidence that individual members display diverse selectivity. Specifically, cytochalasin E acts as an angiogenesis inhibitor and, unlike other cytochalasins, does not inhibit glucose transport.
TLC DATA; DETECTION: H2SO4 SPRAYING & HEAT. GLINSUKON T ET AL; TOXICOL APPL PHARMACOL 32: 135 (1975). TLC DATA; DETECTION: A DARK PURPLE FLUORESCENT SPOT UNDER UV LIGHT AFTER SPRAYING WITH 50% ETHANOLIC H2SO4 & HEATING. WELLS JM ET AL; CAN J MICROBIOL 22: 1137 (1976).
Computed Properties
Molecular Weight:495.6
XLogP3:3.5
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:2
Exact Mass:495.22570239
Monoisotopic Mass:495.22570239
Topological Polar Surface Area:115
Heavy Atom Count:36
Complexity:986
Undefined Atom Stereocenter Count:9
Undefined Bond Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
2-((Butylmethylamino)methyl)-3-pyridinyl dimethylcarbamate ethanedioat e (1:1)
169128-31-8
-
hupehensis saponin E
152464-76-1
-
Streptothricin E sulfate
39380-72-8
-
(8E)-1,3-Diethyl-8-[(2Z)-2-(3-hydroxy-4-oxo-2,5-cyclohexadien-1-y lidene)ethylidene]-7-methyl-3,7,8,9-tetrahydro-1H-purine-2,6-dion e Formula
155272-03-0
-
3-(2-Methoxy-4-{[(2-methylphenyl)sulfonyl]carbamoyl}benzyl)-1-met hyl-N-[(2R)-4,4,4-trifluoro-2-methylbutyl]-1H-indole-5-carboxamid e Formula
136564-68-6
-
5-(Anilinomethylene)-1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrion e Formula
23069-97-8
-
Staunoside E Structure
155661-21-5
-
Erysenegalensein E Structure
154992-17-3
-
What is Isogarciniaxanthone E
659747-28-1
-
What is Rauvotetraphylline E
1422506-53-3